Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Former Lance Armstrong Teammate Kjaergaard Admits to Using Drugs

Former Lance Armstrong Teammate Kjaergaard Admits to Using Drugs
Steffen Kjaergaard of Norway leads U.S. Postal Service teammate George Hincapie and others during stage seven of the 2001 Tour de France. Photographer: Pascal Rondeau/Allsport via Getty Images

Oct. 23 (Bloomberg) -- Norwegian former professional cyclist Steffen Kjaergaard said he used drugs while riding alongside Lance Armstrong, who was stripped of his seven Tour de France titles this week for doping.

“I haven’t been able to carry the lie anymore,” Kjaergaard said today in a press conference broadcast on Norway’s TV2 channel. “I’m hurting on behalf of myself, Norwegian cycling, my closest family and friends.”

Kjaergaard said he used erythropoietin and cortisone while he rode on the U.S. Postal Service team with Armstrong in the early 2000s when the American won some of his seven straight Tour de France titles, according to TV2. He said he couldn’t confirm who else on the team took drugs, although he “assumed many were offered” illegal performance-enhancing products.

International cycling’s ruling body stripped Armstrong of his seven titles and banned him from the sport for life yesterday, endorsing a decision by the U.S. Anti-Doping Agency. The USADA had published evidence from 11 of his former teammates that the 41-year-old had “engaged in serial cheating.”

To contact the reporter on this story: Mikael Holter in Oslo at mholter2@bloomberg.net

To contact the editor responsible for this story: Jonas Bergman at jbergman@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.